August 22, 2025

Nemolizumab Study Tracks 68 Weeks of Relief

A long-term clinical study finds that the biologic therapy nemolizumab, when used with topical corticosteroids, continues to improve itch, sleep, and skin symptoms in prurigo nodularis patients over 68 weeks.

Conexiant

August 21, 2025

Screen Time May Raise Cardiometabolic Risk in Youth

Researchers link increased screen time in children and adolescents to higher cardiometabolic and cardiovascular risk, with sleep duration identified as a key moderating factor.

Conexiant

August 20, 2025

Genes and Environment Shape Infant Sleep Patterns: Study

Twin study reveals how hereditary factors increasingly dominate infant behavior patterns during critical early months of development.

Conexiant

August 20, 2025

One Hour on Phone, Fewer Blinks

Blinking decreases and eye strain increases during one hour of smartphone use, with dynamic screen changes from social media reels creating the highest visual load.

Conexiant

August 20, 2025

Combined Therapy Reduces Binge Eating, Weight

Regulation of Cues plus Behavioral Weight Loss outperforms cognitive behavioral therapy for short-term benefits among veterans with binge eating disorder.

Conexiant

August 20, 2025

Key Stressors Identified in UK Dental Teams

Researchers stress the importance of systemic change, rather than individual resilience resources.

Conexiant

August 20, 2025

Key Stressors Identified in UK Dental Teams

 Researchers stress the importance of systemic change, rather than individual resilience resources.

Conexiant

August 20, 2025

Can a Smartwatch Help Fight Burnout?

Physicians wearing smartwatches with access to their physiological data show reduced burnout and improved resilience after six months of use.

Conexiant

August 19, 2025

High-Dose Buprenorphine and Outcomes in Fentanyl Use

Studies linked higher buprenorphine doses to longer retention, not fewer withdrawal cases.

Conexiant